GENFIT (GNFT) News Today $3.87 -0.19 (-4.68%) As of 08/29/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GNFT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period MASH drug developers rise as FDA accepts lenient trial requirementAugust 27 at 5:13 PM | msn.comFY2025 Earnings Forecast for GENFIT Issued By HC WainwrightAugust 23, 2025 | marketbeat.comFY2025 Earnings Estimate for GENFIT Issued By HC WainwrightAugust 22, 2025 | americanbankingnews.comGENFIT's (GNFT) "Buy" Rating Reiterated at HC WainwrightAugust 21, 2025 | marketbeat.comHC Wainwright Initiates Coverage on GENFIT (NASDAQ:GNFT)August 21, 2025 | americanbankingnews.comGENFIT (NASDAQ:GNFT) Stock Price Down 3.4% - Time to Sell?August 1, 2025 | marketbeat.comKepler Capital Maintained a Buy Rating on Genfit (GNFT)July 28, 2025 | msn.comGENFIT (NASDAQ:GNFT) Shares Up 0.7% - Time to Buy?July 10, 2025 | marketbeat.comGenfit: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJuly 8, 2025 | globenewswire.comGENFIT S.A. Unsponsored ADR (NASDAQ:GNFT) Short Interest Down 25.7% in MayJune 18, 2025 | marketbeat.comGENFIT: June 17, 2025 Combined Shareholders Meeting ResultsJune 17, 2025 | globenewswire.comMillennium Management LLC Invests $611,000 in Genfit S.A. (NASDAQ:GNFT)June 8, 2025 | marketbeat.comGenfit S.A. (NASDAQ:GNFT) Short Interest Down 23.0% in MayJune 3, 2025 | marketbeat.comGenfit (NASDAQ:GNFT) Stock Price Up 0.5% - Here's WhyMay 30, 2025 | marketbeat.comGENFIT S.A.: GENFIT Reports First Quarter 2025 Financial InformationMay 23, 2025 | finanznachrichten.deGENFIT Reports First Quarter 2025 Financial InformationMay 22, 2025 | globenewswire.comGENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen's Iqirvo® in ItalyMay 20, 2025 | globenewswire.comGENFIT S.A.: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)May 15, 2025 | finanznachrichten.deGENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)May 14, 2025 | globenewswire.comGenfit: Iqirvo's Success Can't Outweigh ACLF Pipeline RisksMay 12, 2025 | seekingalpha.comGenfit (NASDAQ:GNFT) Trading Up 2% - Still a Buy?May 9, 2025 | marketbeat.comGENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory DocumentsMay 7, 2025 | globenewswire.comGENFIT to Present Latest ACLF Research at EASL Congress 2025May 5, 2025 | globenewswire.comGENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-FApril 29, 2025 | globenewswire.comGENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025April 28, 2025 | globenewswire.comGENFIT S.A.: GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate UpdateApril 25, 2025 | finanznachrichten.deGENFIT Reports Full-Year 2024 Financial Results and Provides Corporate UpdateApril 24, 2025 | globenewswire.comGenfit (NASDAQ:GNFT) Stock Price Up 2.1% - What's Next?April 16, 2025 | marketbeat.comGenfit (NASDAQ:GNFT) Stock Price Down 2.8% - Time to Sell?March 25, 2025 | marketbeat.comGENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holdersMarch 20, 2025 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for WeekMarch 14, 2025 | msn.comRoyalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEsMarch 10, 2025 | globenewswire.comShort Interest in Genfit S.A. (NASDAQ:GNFT) Declines By 40.5%March 2, 2025 | marketbeat.comGenfit (NASDAQ:GNFT) Shares Down 2% - Time to Sell?March 1, 2025 | marketbeat.comGENFIT Announces Revenues and Cash Position as of December 31, 2024February 27, 2025 | globenewswire.comGENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meetingFebruary 21, 2025 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday TradingFebruary 18, 2025 | msn.comGenfit S.A. (NASDAQ:GNFT) Sees Large Increase in Short InterestFebruary 16, 2025 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for WeekFebruary 14, 2025 | msn.comGENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs HoldersFebruary 14, 2025 | globenewswire.comGenfit's (GNFT) Buy Rating Reiterated at HC WainwrightFebruary 7, 2025 | marketbeat.comFY2025 EPS Estimates for Genfit Cut by Leerink PartnrsFebruary 7, 2025 | marketbeat.comGENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025February 6, 2025 | globenewswire.comFY2024 EPS Estimates for Genfit Reduced by Leerink PartnrsFebruary 6, 2025 | marketbeat.comGenfit SA (GNFT) Receives a Rating Update from a Top AnalystFebruary 3, 2025 | markets.businessinsider.comGENFIT Secures €185 Million Royalty Financing Deal to Bolster R&D and Financial StabilityJanuary 30, 2025 | msn.comGENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution PlanJanuary 30, 2025 | globenewswire.comGENFIT Announces 2025 Financial CalendarJanuary 29, 2025 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Sees Significant Growth in Short InterestJanuary 19, 2025 | marketbeat.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJanuary 13, 2025 | globenewswire.com Get GENFIT News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNFT Media Mentions By Week GNFT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼1.071.05▲Average Medical News Sentiment GNFT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼21▲GNFT Articles Average Week Get the Latest News and Ratings for GNFT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for GENFIT and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies uniQure News Sana Biotechnology News Akebia Therapeutics News Phathom Pharmaceuticals News Amylyx Pharmaceuticals News Anavex Life Sciences News Taysha Gene Therapies News ArriVent BioPharma News Niagen Bioscience News Gyre Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNFT) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENFIT S.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GENFIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNFT Stock Alerts